VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amar Patel, MD
Celgene
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
136 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- St. Joseph'S Hospital and Medical Center
Phoenix, Arizona, United States
- Winthrop P. Rockefeller Cancer Institute - University of Arkansas
Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center
Burbank, California, United States
- Kaiser Permanente Medical Center
Hayward, California, United States
- Long Beach Memorial Medical Center
Long Beach, California, United States
- Kaiser Permanente Medical Center
Oakland, California, United States
- Kaiser Permanente Medical Center
Roseville, California, United States
- Kaiser Permanente Medical Center
Sacramento, California, United States
- Sutter Cancer Center
Sacramento, California, United States
- Kaiser Permanente Medical Center
San Francisco, California, United States
- Kaiser Permanente Medical Center
San Jose, California, United States
- Kaiser Permanente Medical Center
Santa Clara, California, United States
- Kaiser Permanente Medical Center
South San Francisco, California, United States
- Stanford University School of Medicine
Stanford, California, United States
- Kaiser Permanente Medical Center
Vallejo, California, United States
- Kaiser Permanente Medical Center
Walnut Creek, California, United States
- University of Colorado Cancer Center
Aurora, Colorado, United States
- Hartford Hospital
Hartford, Connecticut, United States
- St. Francis Hospital and Medical Center
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Yale - New Haven Hospital
New Haven, Connecticut, United States
- Md Anderson Cancer Center - Orlando
Orlando, Florida, United States
- Women'S Cancer Associates
St. Petersburg, Florida, United States
- Northside Hospital
Atlanta, Georgia, United States
- Georgia Regents University
Augusta, Georgia, United States
- Northeast Georgia Medical Center
Gainesville, Georgia, United States
- Central Georgia Gynecologic Oncology
Macon, Georgia, United States
- Memorial Health University Medical Center
Savannah, Georgia, United States
- St. Joseph'S - Candler Gynecologic Oncology
Savannah, Georgia, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Northwestern University - Robert H. Lurie Comprehensive Cancer Center
Chicago, Illinois, United States
- Rush University Medical Center
Chicago, Illinois, United States
- Sudarshan K. Sharma, Md, Ltd
Hinsdale, Illinois, United States
- Carle Cancer Center
Urbana, Illinois, United States
- Indiana University Medical Center
Indianapolis, Indiana, United States
- St. Vincent Gynecologic Oncology
Indianapolis, Indiana, United States
- Mcfarland Clinic
Ames, Iowa, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- University of Kansas Medical Center
Westwood, Kansas, United States
- Maine Medical Partners Women'S Health
Scarborough, Maine, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2012
- Primary completion
- 31 Jul 2016
- Completion
- 31 Jul 2016
- Last update posted
- 26 Sept 2019
- Registered enrollment
- 297
- Registry id
- NCT01666444
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.